Rogers Campbell
Chief Medical Officer
Sale 10b5-1
- Shares
- 23,933
- Price
- $55.01
- Value
- $1,316,554
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•89 filings
HTFL
Heartflow, Inc.
Net sales of $15.5M over the last 3 months
3 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$15,490,291
0 buyers · 3 sellers
12-month purchases
$1,053,680
1 distinct insiders
12-month sales
$141,321,268
9 distinct insiders
Highlighted alerts
6
33 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get HTFL insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
HTFL overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
100
Raw transactions
Everything returned by the filing
39
Voluntary view
P/S trades after deterministic checks
68
Administrative noise
Stored, never alerted
50
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- M
- Shares
- 5,101
- Price
- $2.22
- Footnotes
- 4
The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026. Includes the sale of 6,503 shares of common stock held and the option exercise and sale of 17,430 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026. These stock options are fully exercisable. The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.
Raspberry interpretation
Informational — no alert
Reason: administrative_code. The trade is reported under a Rule 10b5-1 plan.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Farquhar John C.M.
Chief Executive Officer
Sale 10b5-1
- Shares
- 38,900
- Price
- $49.57
- Value
- $1,928,195
Rogers Campbell
Chief Medical Officer
Sale 10b5-1
- Shares
- 19,682
- Price
- $50.15
- Value
- $987,052
Verghese Vikram
Chief Financial Officer
Sale 10b5-1
- Shares
- 16,766
- Price
- $50.75
- Value
- $850,926
Verghese Vikram
Chief Financial Officer
Sale 10b5-1
- Shares
- 7,579
- Price
- $50.11
- Value
- $379,816
Verghese Vikram
Chief Financial Officer
Sale 10b5-1
- Shares
- 668
- Price
- $50.01
- Value
- $33,408
Verghese Vikram
Chief Financial Officer
Sale 10b5-1
- Shares
- 4,593
- Price
- $50.24
- Value
- $230,744
Verghese Vikram
Chief Financial Officer
Sale 10b5-1
- Shares
- 29,714
- Price
- $50.06
- Value
- $1,487,459
Farquhar John C.M.
Chief Executive Officer
Sale 10b5-1
- Shares
- 3,890
- Price
- $50.00
- Value
- $194,500
Farquhar John C.M.
Chief Executive Officer
Sale 10b5-1
- Shares
- 35,010
- Price
- $46.42
- Value
- $1,625,105
Verghese Vikram
Chief Financial Officer
Sale 10b5-1
- Shares
- 6,640
- Price
- $50.03
- Value
- $332,212
Verghese Vikram
Chief Financial Officer
Sale 10b5-1
- Shares
- 27,540
- Price
- $49.69
- Value
- $1,368,471
Verghese Vikram
Chief Financial Officer
Sale 10b5-1
- Shares
- 5,876
- Price
- $50.60
- Value
- $297,326
Farquhar John C.M.
Chief Executive Officer
Sale 10b5-1
- Shares
- 27,230
- Price
- $50.00
- Value
- $1,361,500
Farquhar John C.M.
Chief Executive Officer
Sale 10b5-1
- Shares
- 32,676
- Price
- $45.00
- Value
- $1,470,420
Rogers Campbell
Chief Medical Officer
Sale 10b5-1
- Shares
- 9,219
- Price
- $41.23
- Value
- $380,099
Farquhar John C.M.
Chief Executive Officer
Sale 10b5-1
- Shares
- 15,560
- Price
- $39.06
- Value
- $607,774
Farquhar John C.M.
Chief Executive Officer
Sale 10b5-1
- Shares
- 22,562
- Price
- $28.31
- Value
- $638,730
Rogers Campbell
Chief Medical Officer
Sale 10b5-1
- Shares
- 9,219
- Price
- $25.72
- Value
- $237,113
Farquhar John C.M.
Chief Executive Officer
Sale 10b5-1
- Shares
- 22,562
- Price
- $27.75
- Value
- $626,096
Farquhar John C.M.
Chief Executive Officer
Sale 10b5-1
- Shares
- 38,900
- Price
- $35.00
- Value
- $1,361,500
Farquhar John C.M.
Chief Executive Officer
Sale 10b5-1
- Shares
- 22,562
- Price
- $28.50
- Value
- $643,017
Rogers Campbell
Chief Medical Officer
Sale 10b5-1
- Shares
- 9,219
- Price
- $28.34
- Value
- $261,266
Farquhar John C.M.
Chief Executive Officer
Sale 10b5-1
- Shares
- 22,562
- Price
- $29.12
- Value
- $657,005
Bain Capital Life Sciences Investors, LLC
10% owner
SaleAlert
- Shares
- 56,224
- Price
- $30.05
- Value
- $1,689,531
Bain Capital Life Sciences Investors, LLC
10% owner
SaleAlert
- Shares
- 892,533
- Price
- $29.18
- Value
- $26,044,113
Bain Capital Life Sciences Investors, LLC
10% owner
SaleAlert
- Shares
- 797,133
- Price
- $29.37
- Value
- $23,411,796
Bain Capital Life Sciences Investors, LLC
10% owner
SaleAlert
- Shares
- 254,110
- Price
- $30.51
- Value
- $7,752,896
Farquhar John C.M.
Chief Executive Officer
Sale 10b5-1
- Shares
- 22,562
- Price
- $26.72
- Value
- $602,857
Rogers Campbell
Chief Medical Officer
Sale 10b5-1
- Shares
- 64,533
- Price
- $24.64
- Value
- $1,590,093
Rogers Campbell
Chief Medical Officer
Sale 10b5-1
- Shares
- 64,533
- Price
- $25.69
- Value
- $1,658,033
Farquhar John C.M.
Chief Executive Officer
Sale 10b5-1
- Shares
- 9,725
- Price
- $25.00
- Value
- $243,125
Farquhar John C.M.
Chief Executive Officer
Sale 10b5-1
- Shares
- 12,837
- Price
- $22.66
- Value
- $290,886
Cullivan Julie A
Director
Sale 10b5-1
- Shares
- 9,122
- Price
- $25.00
- Value
- $228,050
Rogers Campbell
Chief Medical Officer
Sale 10b5-1
- Shares
- 65,153
- Price
- $24.49
- Value
- $1,595,486
Farquhar John C.M.
Chief Executive Officer
Sale 10b5-1
- Shares
- 22,562
- Price
- $27.46
- Value
- $619,553
Cullivan Julie A
Director
Sale 10b5-1
- Shares
- 8,000
- Price
- $27.32
- Value
- $218,560
Bain Capital Life Sciences Investors, LLC
10% owner
SaleAlert
- Shares
- 2,000,000
- Price
- $28.05
- Value
- $56,100,000
Lightcap Jeffrey C
Director
PurchaseAlert
- Shares
- 40,000
- Price
- $26.34
- Value
- $1,053,680
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Oct 22, 2026 | Rogers Campbell Chief Medical Officer | Sale | 23,933 | $55.01 | $1,316,554 | |
| Oct 12, 2026 | Farquhar John C.M. Chief Executive Officer | Sale | 38,900 | $49.57 | $1,928,195 | |
| Sep 18, 2026 | Rogers Campbell Chief Medical Officer | Sale | 19,682 | $50.15 | $987,052 | |
| Sep 18, 2026 | Verghese Vikram Chief Financial Officer | Sale | 16,766 | $50.75 | $850,926 | |
| Sep 17, 2026 | Verghese Vikram Chief Financial Officer | Sale | 7,579 | $50.11 | $379,816 | |
| Sep 15, 2026 | Verghese Vikram Chief Financial Officer | Sale | 668 | $50.01 | $33,408 | |
| Sep 14, 2026 | Verghese Vikram Chief Financial Officer | Sale | 4,593 | $50.24 | $230,744 | |
| Sep 11, 2026 | Verghese Vikram Chief Financial Officer | Sale | 29,714 | $50.06 | $1,487,459 | |
| Sep 11, 2026 | Farquhar John C.M. Chief Executive Officer | Sale | 3,890 | $50.00 | $194,500 | |
| Sep 10, 2026 | Farquhar John C.M. Chief Executive Officer | Sale | 35,010 | $46.42 | $1,625,105 | |
| Sep 08, 2026 | Verghese Vikram Chief Financial Officer | Sale | 6,640 | $50.03 | $332,212 | |
| Sep 03, 2026 | Verghese Vikram Chief Financial Officer | Sale | 27,540 | $49.69 | $1,368,471 | |
| Sep 02, 2026 | Verghese Vikram Chief Financial Officer | Sale | 5,876 | $50.60 | $297,326 | |
| Aug 21, 2026 | Farquhar John C.M. Chief Executive Officer | Sale | 27,230 | $50.00 | $1,361,500 | |
| Aug 18, 2026 | Farquhar John C.M. Chief Executive Officer | Sale | 32,676 | $45.00 | $1,470,420 | |
| Aug 17, 2026 | Rogers Campbell Chief Medical Officer | Sale | 9,219 | $41.23 | $380,099 | |
| Aug 14, 2026 | Farquhar John C.M. Chief Executive Officer | Sale | 15,560 | $39.06 | $607,774 | |
| Aug 10, 2026 | Farquhar John C.M. Chief Executive Officer | Sale | 22,562 | $28.31 | $638,730 | |
| Jul 15, 2026 | Rogers Campbell Chief Medical Officer | Sale | 9,219 | $25.72 | $237,113 | |
| Jul 10, 2026 | Farquhar John C.M. Chief Executive Officer | Sale | 22,562 | $27.75 | $626,096 | |
| Jun 24, 2026 | Farquhar John C.M. Chief Executive Officer | Sale | 38,900 | $35.00 | $1,361,500 | |
| Jun 10, 2026 | Farquhar John C.M. Chief Executive Officer | Sale | 22,562 | $28.50 | $643,017 | |
| May 18, 2026 | Rogers Campbell Chief Medical Officer | Sale | 9,219 | $28.34 | $261,266 | |
| May 11, 2026 | Farquhar John C.M. Chief Executive Officer | Sale | 22,562 | $29.12 | $657,005 | |
| Apr 30, 2026 | Bain Capital Life Sciences Investors, LLC 10% owner | Sale | 56,224 | $30.05 | $1,689,531 | |
| Apr 30, 2026 | Bain Capital Life Sciences Investors, LLC 10% owner | Sale | 892,533 | $29.18 | $26,044,113 | |
| Apr 29, 2026 | Bain Capital Life Sciences Investors, LLC 10% owner | Sale | 797,133 | $29.37 | $23,411,796 | |
| Apr 28, 2026 | Bain Capital Life Sciences Investors, LLC 10% owner | Sale | 254,110 | $30.51 | $7,752,896 | |
| Apr 10, 2026 | Farquhar John C.M. Chief Executive Officer | Sale | 22,562 | $26.72 | $602,857 | |
| Apr 01, 2026 | Rogers Campbell Chief Medical Officer | Sale | 64,533 | $24.64 | $1,590,093 | |
| Mar 19, 2026 | Rogers Campbell Chief Medical Officer | Sale | 64,533 | $25.69 | $1,658,033 | |
| Mar 18, 2026 | Farquhar John C.M. Chief Executive Officer | Sale | 9,725 | $25.00 | $243,125 | |
| Mar 10, 2026 | Farquhar John C.M. Chief Executive Officer | Sale | 12,837 | $22.66 | $290,886 | |
| Mar 05, 2026 | Cullivan Julie A Director | Sale | 9,122 | $25.00 | $228,050 | |
| Feb 12, 2026 | Rogers Campbell Chief Medical Officer | Sale | 65,153 | $24.49 | $1,595,486 | |
| Feb 10, 2026 | Farquhar John C.M. Chief Executive Officer | Sale | 22,562 | $27.46 | $619,553 | |
| Feb 05, 2026 | Cullivan Julie A Director | Sale | 8,000 | $27.32 | $218,560 | |
| Feb 04, 2026 | Bain Capital Life Sciences Investors, LLC 10% owner | Sale | 2,000,000 | $28.05 | $56,100,000 | |
| Dec 16, 2025 | Lightcap Jeffrey C Director | Purchase | 40,000 | $26.34 | $1,053,680 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.